+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Acute Myeloid Leukemia (AML) Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Class (Chemotherapy, Targeted Therapy, Immunotherapy, Stem-Cell Transplant Support, Supportive Care Drugs), By Mechanism (FLT3 Inhibitors, IDH1, BCL-2 Inhibitors, Hedgehog Pathway Inhibitors, CD33-Directed Antibody–Drug Conjugates), By Patient Demographic (Pediatric , Adult , Geriatric ), By End-User (Hospitals, Specialty Oncology Centers, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Acute Myeloid Leukemia (AML) Therapeutics Market size is forecast to increase from $3.83 Billion in 2026 to $6.29 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005407
Pages: 213 Pages

Acute Lymphocytic Leukemia Market Size, Share and Growth Outlook, 2026: Analysis By Cell Type (B-cell Precursor ALL, T-cell ALL, Philadelphia Chromosome ), By Therapy Type (Chemotherapy, Targeted Therapy , Immunotherapy , CAR-T Cell Therapy, Stem-Cell Transplantation , Radiation Therapy), By Age Group (Pediatric , Adults , Geriatric ), By Route of Administration (Injectable , Oral), By Distribution Channel (Hospital Pharmacies, Oncology Specialty Pharmacies, Retail Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Acute Lymphocytic Leukemia Market size is forecast to increase from $4.07 Billion in 2026 to $7.1 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005406
Pages: 224 Pages

Acute Ischemic Stroke Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Thrombolytics , Anticoagulants , Antiplatelet Agents , Antihypertensive Agents, Statins / Lipid-Lowering Agents, Neuroprotective Agents), By Route of Administration (Parenteral , Oral), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers , Long-term Care Centers) Companies, and Country Forecast, 2021 to 2034

Global Acute Ischemic Stroke Therapeutics Market size is forecast to increase from $7.62 Billion in 2026 to $13.59 Billion in 2034 at a CAGR of 7.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005405
Pages: 215 Pages

Acute Ischemic Stroke Diagnosis Market Size, Share and Growth Outlook, 2026: Analysis By Diagnostic Technology (Computed Tomography , Magnetic Resonance Imaging , Cerebral Angiography , Carotid & Trans-cranial Ultrasound, Nuclear Imaging , Blood-based Biomarker Tests, Electrocardiography & Echocardiography), By AI Software Function (Early-Event Triage & Alerting, Large-Vessel-Occlusion , Perfusion Mismatch Quantification, Hemorrhage Exclusion), By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers , Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Acute Ischemic Stroke Diagnosis Market size is forecast to increase from $2.1 Billion in 2026 to $4.7 Billion in 2034 at a CAGR of 10.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005404
Pages: 220 Pages

Acute Hospital Care Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (In-Patient Services, Intensive Care Units , Emergency & Trauma Care, General Surgery, Specialty Surgery , Diagnostics & Imaging, Rehabilitation & Ancillary Services), By Facility Type (General Acute Care Hospitals, Specialized Hospitals, Psychiatric Hospitals, Long-Term Acute Care Facilities, Rehabilitation Hospitals), By Ownership (Public / Government, Private For-Profit, Not-For-Profit / Charitable), By Bed Capacity (Small , Medium , Large / Tertiary) Companies, and Country Forecast, 2021 to 2034

Global Acute Hospital Care Market size is forecast to increase from $4084.98 Billion in 2026 to $6659.72 Billion in 2034 at a CAGR of 6.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005403
Pages: 217 Pages

Acute External Ventricular Drain Market Size, Share and Growth Outlook, 2026: Analysis By Application (Traumatic Brain Injury , Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Hydrocephalus Management, Others), By Patient Type (Adult, Pediatric), By Distribution Channel (Hospital Vendor Agreements, Medical Device Distributors, E-commerce Platforms) Companies, and Country Forecast, 2021 to 2034

Global Acute External Ventricular Drain Market size is forecast to increase from $394.89 Million in 2026 to $741.81 Million in 2034 at a CAGR of 8.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005402
Pages: 221 Pages

Acute Coronary Syndrome (ACS) Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Indication (ST-Elevation Myocardial Infarction , Non-ST-Elevation Myocardial Infarction , Unstable Angina), By Drug Class (Antiplatelet Drugs, Anticoagulants, Thrombolytic Agents, Beta-Blockers, Statins, ACE Inhibitors, Others), By Route of Administration (Oral , Injectable ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Ambulatory Care Centers) Companies, and Country Forecast, 2021 to 2034

Global Acute Coronary Syndrome (ACS) Therapeutics Market size is forecast to increase from $13.09 Billion in 2026 to $23.17 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005401
Pages: 214 Pages

Acute Care Telemedicine Market Size, Share and Growth Outlook, 2026: Analysis By Delivery Mode (Clinician-to-Patient , Clinician-to-Clinician ), By Application (Teleradiology, Telepsychiatry, Tele-ICU , Teleneurology , Telenephrology, Telecardiology, Tele-Emergency Medicine), By Component (Software and Platforms, Hardware , Services ), By End-User (Hospitals and Specialty Clinics, Trauma and Emergency Centers, Ambulatory Care Centers) Companies, and Country Forecast, 2021 to 2034

Global Acute Care Telemedicine Market size is forecast to increase from $34.84 Billion in 2026 to $111.11 Billion in 2034 at a CAGR of 15.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005400
Pages: 211 Pages

Acute Care Needleless Connectors Market Size, Share and Growth Outlook, 2026: Analysis By Internal Mechanism (Positive Fluid Displacement, Negative Fluid Displacement, Neutral Fluid Displacement, Anti-Reflux Needleless Connectors), By Device Complexity (Simple Needleless Connectors , Complex Needleless Connectors ), By Application (Infusion , Transfusion of Blood & Blood Products, Blood Collection ), By End-User (Hospitals and Emergency Care Units, Clinics and Ambulatory Surgical Centers , Outpatient Care) Companies, and Country Forecast, 2021 to 2034

Global Acute Care Needleless Connectors Market size is forecast to increase from $1.26 Billion in 2026 to $2.44 Billion in 2034 at a CAGR of 8.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005399
Pages: 228 Pages

Acute Bacterial Skin and Skin Structure Infections Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Retinoids, Lipoglycopeptides, Oxazolidinones, Tetracyclines, Cephalosporins, Fluoroquinolones, Glycopeptides & Cyclic Lipopeptides), By Route of Administration (Oral, Intravenous , Topical), By Type of Infection (Community-Acquired ABSSSI, Hospital-Acquired ABSSSI), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Acute Bacterial Skin and Skin Structure Infections Market size is forecast to increase from $3.98 Billion in 2026 to $7.5 Billion in 2034 at a CAGR of 8.24% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005398
Pages: 221 Pages